Preclinical experiments with a triple immunotherapy combination shows promise with significantly improved anti-tumour responses for pancreatic cancer, a particularly lethal type of cancer and a cancer that had so far resisted approaches to treat it using immunotherapy.
related: #pancreatic_cancer #combination_therapy #immunotherapy